Literature DB >> 6725216

Plasma catecholamine metabolites and early response to haloperidol.

M B Bowers, M E Swigar, P I Jatlow, N Goicoechea.   

Abstract

Plasma homovanillic acid (HVA) and methoxyhydroxyphenyl glycol (MHPG) as well as serum haloperidol and prolactin were measured in patients admitted to a general hospital psychiatric service for treatment of acute psychosis. At 10 days, good responders compared to poor responders had higher mean plasma HVA values before and during the first week of treatment with 0.2-0.4 mg/kg haloperidol per day. MHPG values showed a similar pattern, although no significant differences were obtained between or within the two groups. Females predominated among good responders; neither DSM-III diagnoses nor steady state haloperidol levels differed significantly between the two groups. Significant correlations within some patients were obtained between prolactin and haloperidol (positive), prolactin and MHPG (negative), and HVA and MHPG (positive). Plasma catecholamine metabolites deserve further study as possible markers of early response to the treatment of acute psychosis with modest doses of neuroleptic drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6725216

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  14 in total

1.  Clozapine in China: a review and preview of US/PRC collaboration.

Authors:  W Z Potter; G N Ko; L D Zhang; W W Yan
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.

Authors:  E Suzuki; S Kanba; H Koshikawa; M Nibuya; G Yagi; M Asai
Journal:  J Psychiatry Neurosci       Date:  1996-05       Impact factor: 6.186

3.  An open study of fenfluramine in hospitalized young autistic children.

Authors:  M Campbell; R Perry; B B Polonsky; S I Deutsch; M Palij; D Lukashok
Journal:  J Autism Dev Disord       Date:  1986-12

Review 4.  Sex steroids and schizophrenia.

Authors:  Julie A Markham
Journal:  Rev Endocr Metab Disord       Date:  2012-09       Impact factor: 6.514

5.  Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol: the effect of regular/intermittent dosing.

Authors:  J G Csernansky; E P Bellows; D E Barnes; L Lombrozo
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Concentrations of homovanillic Acid and gonadal hormones in the serum of male schizophrenic patients.

Authors:  S L Gong; J Wei; C N Ramchand; R Ramchand; G P Hemmings
Journal:  Indian J Psychiatry       Date:  1993-07       Impact factor: 1.759

7.  Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function.

Authors:  A Wolkin; E Duncan; M Sanfilipo; S Wieland; T B Cooper; J Rotrosen
Journal:  J Neural Transm Gen Sect       Date:  1994

8.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

9.  Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

10.  On the selection of mice for haloperidol response and non-response.

Authors:  R Hitzemann; K Dains; C M Bier-Langing; N R Zahniser
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.